检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:梁文华[1] 丁继军 林飞[3] 唐亮[4] 李解贵[1] 彭寒林[1] 周炜[1]
机构地区:[1]湖南省衡阳市解放军第169医院内三科,衡阳421002 [2]张家港奥洋医院心内科,张家港215600 [3]第二军医大学附属长海医院,上海200433 [4]中南大学湘雅二医院心内科,湖南410011
出 处:《重庆医科大学学报》2010年第3期427-429,共3页Journal of Chongqing Medical University
摘 要:目的:观察早期使用脂质载体前列腺素E1对经皮冠状动脉介入治疗(Percutaneous coronary intervention,PCI)患者血浆炎症因子的影响。方法:74例行PCI治疗的患者随机分成实验组和对照组。前者入选后给予PGE120μg+生理盐水40ml静脉注射,Bid×3d,对照组患者则不给。其余基础治疗措施相同。于PCI术前1d、术后2d、术后5d、术后4周查CRP、IL-6、TNF-α,并观察观察术后60d内早期心脏事件发生情况。结果:两组患者经PCI治疗后1d,CRP水平有所上升,与同组术前1d相比有显著差异(P<0.05),但与对照组相比均未见有差异(P>0.05)。术后5d~4周,实验组的水平已较术前有所下降(P<0.05),对照组较术前亦有下降(P<0.05),并且实验组CRP的水平较对照组下降更为明显(P>0.05)。炎症因子IL-6、TNF-α和CRP表现出一样的变化趋势。并且,用药期间2组未出现不良反应,安全性良好。结论:在PCI术后早期CRP、IL-6和TNF-α可有升高,但早期应用Lipo-PGE1后,可有效抑制炎症因子水平。Objective:To observe the inflammatory factors for early use of lipid carriers prostaglandin E1 on percutaneous coronary intervention(PCI).Method:74 patients treated with PCI were randomly divided into experimental and control groups.PGE1 20μg + 40 ml normal saline intravenously,Bid × 3 d,were used in experimental groups,but not to the patients in the control group.The basis treatment was the same.CRP,IL-6,TNF-α were checked in the pre-operative 1 d,after 2 d,after 5 d,after 4 w,and after 60 d,the early incidence of cardiac events were observed.Results:CRP levels in every patients for two groups increased at 1 d(P0.05),CRP level in the experimental group compared with the control group were not different(P0.05).After 5 d~4 w,CRP level in the experimental group were declined than 1 d(P 0.05),also dropped than the control group(P 0.05),and the level of CRP in the experimental group decreased more than the control group(P0.05).Inflammatory factor IL-6,TNF-α and CRP showed the same trend.Conclusions:CRP,IL-6 and TNF-α may have increased in the early stage of post-PCI,and the use of Lipo-PGE1 may be effective in containing the level of inflammatory factors.
分 类 号:R541.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49